Synthetic data will open up doors for entirely new collaborations between healthcare providers and healthcare innovators.
CEO, Gesund Digital
The barriers to access sensitive data, such as social and health data, are very high. Synthetic data has been proposed as one solution to facilitate data-led R&D and research, but incentives to create and share such data remain limited.
Due to these factors, access to RWD is mostly limited to academic research and synthetic data is mostly created for individual projects’ needs, which makes it very costly. This leads to a situation where innovations based on sensitive data are either slow or impossible get off the ground. This is particularly true concerning innovations stemming from outside of healthcare or life-science industries.
We plan to release a first version of our platform during 2023. In case you are interested in partnering with us, or want to learn more, please be in touch!